肝硬化并发门静脉血栓的危险因素及中医证候特点

吕靖; 董思思; 顾宏图; 赵长青; 刘成海

doi:10.3969/j.issn.1001-5256.2019.10.016

肝硬化并发门静脉血栓的危险因素及中医证候特点

DOI: 10.3969/j.issn.1001-5256.2019.10.016

1. 上海中医药大学附属曙光医院肝二科
2. 上海中医药大学肝病研究所

基金项目:

国家自然科学基金(81603467)；上海市促进市级医院临床技能与临床创新能力三年行动计划项目·重大疾病临床技能提升项目(16CR1026B)；

详细信息

中图分类号: R259
计量
- 文章访问数: 1683
- HTML全文浏览量: 104
- PDF下载量: 255
- 被引次数: 0
出版历程
- 收稿日期: 2019-05-10
- 出版日期: 2019-10-20

TCM syndrome characteristics of portal vein thrombosis in patients with liver cirrhosis and related risk factors

Second Department of Hepatology,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Research funding:

摘要

摘要:
目的探讨肝硬化门静脉血栓（PVT）发生的危险因素及中医证候特点。方法选取2015年1月-2019年3月在上海中医药大学附属曙光医院住院的并发PVT的肝硬化患者62例,同时随机抽取66例无PVT肝硬化患者作为对照。收集并比较两组患者的临床资料。计量资料组间比较采用独立样本t检验或Mann-Whitney U秩和检验,计数资料组间比较采用χ2检验或Fisher精确概率法,多因素分析采用非条件多因素logistic回归。结果单因素分析结果显示,PVT组与无PVT组患者在肝硬化病因（χ2=12. 902,P=0. 036）、ALT（Z=-2. 571,P=0. 010）、AST（Z=-2. 801,P=0. 005）、胆碱酯酶（t=-2. 579,P=0. 011）、纤维蛋白降解产物（Z=-4. 410,P <0. 001）、D-二聚体（Z=-4. 888,P <0. 001）、中性粒细胞百分比（Z=-3. 124,P=0. 002）、门静脉主干内径（t=2. 572,P=0. 012）、门静脉血流速度（t=-2. 441,P=0. 016）、脾静脉内径（t=3. 175,P=0....
- 肝硬化 /
- 门静脉血栓 /
- 危险因素 /
- 证候
Abstract:
Objective To investigate the traditional Chinese medicine(TCM) syndrome characteristics of portal vein thrombosis(PVT) in patients with liver cirrhosis and related risk factors. Methods A total of 62 patients with liver cirrhosis and PVT who were hospitalized in Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine from January 2015 to March 2019 were enrolled as PVT group,and 66 liver cirrhosis patients without PVT were enrolled as non-PVT group. Related clinical data were compared between the two groups. The independent samples t-test or the Mann-Whitney U test was used for comparison of continuous data between groups,the chi-square test or the Fisher's exact test was used for comparison of categorical data between groups,and the unconditional multivariate logistic regression was used for multivariate analysis. Results The univariate analysis showed that there were significant differences between the PVT group and the non-PVT group in the etiology of liver cirrhosis(χ2= 12. 902,P = 0. 036),alanine aminotransferase(Z =-2. 571,P =0. 010),aspartate aminotransferase(Z =-2. 801,P = 0. 005),cholinesterase(t =-2. 579,P = 0. 011),fibrinogen degradation product(Z=-4. 410,P < 0. 001),D-dimer(Z =-4. 888,P < 0. 001),percentage of neutrophils(Z =-3. 124,P = 0. 002),internal diameter of the main portal vein(t = 2. 572,P = 0. 012),blood flow velocity of the portal vein(t =-2. 441,P = 0. 016),diameter of the splenic vein(t = 3. 175,P = 0. 002),spleen thickness(t = 4. 575,P < 0. 001),spleen length(Z =-4. 028,P < 0. 001),and volume of peritoneal effusion(t = 2. 273,P = 0. 025). The logistic regression analysis showed that D-dimer(odds ratio [OR]= 2. 078,95% confidence interval [CI]: 1. 293-3. 339,P = 0. 003) and spleen length(OR = 1. 964,95% CI: 1. 228-3. 142,P = 0. 005) were independent risk factors for PVT in patients with liver cirrhosis. Fatigue(100%),splenomegaly(74. 19%),abdominal distension(46. 77%),severe esophagogastric varices(48. 29%),history of variceal bleeding(40. 32%),light-reddish tongue(43. 55%),and stringy/thready pulse(96. 77%) were the main characteristics of patients with liver cirrhosis and PVT,which were consistent with the manifestations of Qi deficiency and blood stasis syndrome. Conclusion An increase in D-dimer level and a long spleen length are independent risk factors for PVT in patients with liver cirrhosis,and the syndrome characteristics of such patients are consistent with the manifestations of Qi deficiency and blood stasis syndrome.
- liver cirrhosis /
- portal vein thrombosis /
- risk factors /
- SYMPTOM COMPLEX

HTML全文

参考文献(13)

[1]RAJANI R,BJORNSSON E,BERGQUIST A,et al.The epidemiology and clinical features of portal vein thrombosis:A multicentre study[J].Aliment Pharmacol Ther,2010,32(9):1154-1162．

[2]OGREN M,BERGQVIST D,BJORCK M,et al.Portal vein thrombosis:Prevalence,patient characteristics and lifetime risk:A population study based on 23,796 consecutive autopsies[J].World J Gastroenterol,2006,12(13):2115-2119．

[3]INTAGLIATA NM,CALDWELL SH,TRIPODI A.Diagnosis,development,and treatment of portal vein thrombosis in patients with and without cirrhosis[J].Gastroenterology,2019,156(6):1582-1599．

[4]TANG W,WANG Y,ZHAO XY,et al.Impact of portal vein thrombosis on prognosis of patients with liver cirrhosis[J].JClin Hepatol,2017,33(3):466-471.(in Chinese)汤雯，王宇，赵新颜，等．门静脉血栓对肝硬化患者预后的影响[J]．临床肝胆病杂志，2017,33(3):466-471．

[5]NERY F,CHEVRET S,CONDAT B,et al.Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis:Results of a longitudinal study[J].Hepatology,2015,61(2):660-667．

[6]Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese,Medical Association.The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J].J Clin Hepatol,2015,31(12):1941-1960.(in Chinese)中华医学会肝病学分会，中华医学会感染病学分会．慢性乙型肝炎防治指南(2015年更新版)[J]．临床肝胆病杂志，2015,31(12):1941-1960．

[7]TRIPODI A,MANNUCCI PM.The coagulopathy of chronic liver disease[J].N Engl J Med,2011,365(2):147-156．

[8]ZHANG DL,HAO JY,YANG N.Value of D-dimer and protein S for diagnosis of portal vein thrombosis in patients with liver cirrhosis[J].J Int Med Res,2013,41(3):664-672．

[9]DAI J,QI X,LI H,et al.Role of D-dimer in the development of portal vein thrombosis in liver cirrhosis:A meta-analysis[J].Saudi J Gastroenterol,2015,21(3):165-174．

[10]ZOCCO MA,DI SE,DE CR,et al.Thrombotic risk factors in patients with liver cirrhosis:Correlation with MELD scoring system and portal vein thrombosis development[J].J Hepatol,2009,51(4):682-689．

[11]WU S,WU Z,ZHANG X,et al.The incidence and risk factors of portal vein system thrombosis after splenectomy and pericardial devascularization[J].Turk J Gastroenterol,2015,26(5):423-428．

[12]ZHANG Q,LIU P,ZHANG HW,et al.Study on the patterns of TCM syndrome differentiation of 900 patients with posthepatitic cirrhosis[J].Chin J Integr Trad West Med,2006,26(8):694-697.(in Chinese)张琴，刘平，章浩伟，等．900例肝炎后肝硬化中医证候判别模式的研究[J]．中国中西医结合杂志，2006,26(8):694-697．

[13]WANLESS IR,WONG F,BLENDIS LM,et al.Hepatic and portal vein thrombosis in cirrhosis:Possible role in development of parenchymal extinction and portal hypertension[J].Hepatology,1995,21(5):1238-1247.

施引文献

资源附件(0)

访问统计